Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-24

FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Tobramycin and Dexamethasone from Sandoz, updating the existing NDA for this ophthalmic antibiotic/steroid combi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBRAMYCIN AND DEXAMETHASONE (tobramycin and dexamethasone)

Snippet

SUPPL AP for TOBRAMYCIN AND DEXAMETHASONE (TOBRAMYCIN AND DEXAMETHASONE)